FDA halts trials of Amgen drug in children, cites death
(Reuters) - The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen Inc's Sensipar after the reported death of a 14-year-old patient taking part in a study of the drug used to lower calcium levels in the blood.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Calcium | Children | Clinical Trials | Food and Drug Administration (FDA) | Health | Pediatrics | Sensipar | Study